<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: The mammalian target of <z:chebi fb="0" ids="9168">rapamycin</z:chebi> is a conserved protein kinase known to regulate protein synthesis, cell size and proliferation </plain></SENT>
<SENT sid="1" pm="."><plain>Aberrant regulation of mammalian target of <z:chebi fb="0" ids="9168">rapamycin</z:chebi> activity has been observed in <z:e sem="disease" ids="C0376544" disease_type="Neoplastic Process" abbrv="">hematopoietic malignancies</z:e>, including <z:hpo ids='HP_0002488'>acute leukemias</z:hpo> and <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo>, suggesting that correct regulation of mammalian target of <z:chebi fb="0" ids="9168">rapamycin</z:chebi> is critical for <z:mpath ids='MPATH_458'>normal</z:mpath> hematopoiesis </plain></SENT>
<SENT sid="2" pm="."><plain>DESIGN AND METHODS: An ex vivo granulocyte differentiation system was utilized to investigate the role of mammalian target of <z:chebi fb="0" ids="9168">rapamycin</z:chebi> in the regulation of myelopoiesis </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: Inhibition of mammalian target of <z:chebi fb="0" ids="9168">rapamycin</z:chebi> activity, with the pharmacological inhibitor <z:chebi fb="0" ids="9168">rapamycin</z:chebi>, dramatically reduced hematopoietic progenitor expansion, without altering levels of <z:mpath ids='MPATH_3'>apoptosis</z:mpath> or maturation </plain></SENT>
<SENT sid="4" pm="."><plain>Moreover, analysis of distinct hematopoietic progenitor populations revealed that <z:chebi fb="0" ids="9168">rapamycin</z:chebi> treatment inhibited the expansion potential of committed CD34(+) lineage-positive progenitors, but did not affect early hematopoietic progenitors </plain></SENT>
<SENT sid="5" pm="."><plain>Further examinations showed that these effects of <z:chebi fb="0" ids="9168">rapamycin</z:chebi> on progenitor expansion might involve differential regulation of protein kinase B and mammalian target of <z:chebi fb="0" ids="9168">rapamycin</z:chebi> signaling </plain></SENT>
<SENT sid="6" pm="."><plain>CONCLUSIONS: Together, these results indicate that mammalian target of <z:chebi fb="0" ids="9168">rapamycin</z:chebi> activity is essential for expansion of CD34(+) hematopoietic progenitor cells during myelopoiesis </plain></SENT>
<SENT sid="7" pm="."><plain>Modulation of the mammalian target of <z:chebi fb="0" ids="9168">rapamycin</z:chebi> pathway may be of benefit in the design of new therapies to control <z:e sem="disease" ids="C0376545" disease_type="Neoplastic Process" abbrv="">hematologic malignancies</z:e> </plain></SENT>
</text></document>